Clinical trial of human embryonic stem cell therapy in US
Geron Initiates Clinical Trial of Human Embryonic Stem Cell-Based Therapy — First Patient Treated at Shepherd Center in Atlanta – Geron Corporation (Nasdaq: GERN) announced the enrollment of the first patient in the company’s clinical trial of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells, GRNOPC1.